Patent details

EP1888059 Title: REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS

Basic Information

Publication number:
EP1888059
PCT Application Number:
PCT/US/2006/021295
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP067845305
PCT Publication Number:
WO/2006/130775
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS
French Title of Invention:
PRODUITS THERAPEUTIQUES ACTIFS EN REDUCTION-OXYDATION DESTINES AU TRAITEMENT DE MALADIES MITOCHONDRIALES ET D'AUTRES ETATS AINSI QUE LA MODULATION DE BIO-MARQUEURS D'ENERGIE
German Title of Invention:
REDOXAKTIVE THERAPEUTIK ZUR BEHANDLUNG VON MITOCHONDRIALEN ERKRANKUNGEN UND ANDEREN ZUSTÄNDEN SOWIE MODULATION VON ENERGIE-BIOMARKERN
SPC Number:

Dates

Filing date:
01/06/2006
Grant date:
17/12/2014
EP Publication Date:
17/12/2014
PCT Publication Date:
07/12/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/02/2008
EP B1 Publication Date:
17/12/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/06/2019
Expiration date:
01/06/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/07/2017
 
 

Name:
BioElectron Technology Corporation
Address:
350 North Bernardo Avenue, Mountain View, CA 94043, United States (US)

History of Owners

From:
01/06/2006
To:
12/07/2017

Name:
Edison Pharmaceuticals Inc.
Address:
350 North Bernardo Avenue, Mountain View, CA 94043, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
25/02/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HECHT Sidney M., University of Virginia
Address:
United States (US)

2

Name:
MILLER Guy M., Edison Pharmaceuticals, Inc.
Address:
United States (US)

Priority

1

Priority Number:
686826 P
Priority Date:
01/06/2005
Priority Country:
United States (US)

2

Priority Number:
701815 P
Priority Date:
21/07/2005
Priority Country:
United States (US)

3

Priority Number:
776028 P
Priority Date:
22/02/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/355;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2017/04
Publication date:
04/08/2017
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20170000232A
Date Registered:
12/07/2017
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
MARKS & CLERK LLP
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
BioElectron Technology Corporation
Address:
350 North Bernardo Avenue, Mountain View, CA 94043, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/05/2018
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
12/07/2017 Request For Change 3